SCHEMBL28618322

SCHEMBL28618322

CS(=O)(=O)c1cn(-c2ccncn2)c2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
RPS6KA5 O75582 1/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.43
CYP17A1 P05093 1/20 0.39
LCK P06239 1/20 0.35
HTR6 P50406 1/20 0.34
CDC7 O00311 3/20 0.34
CDK2 P24941 2/20 0.34
CHRM1 P11229 1/20 0.33
SPR P35270 1/20 0.33
HSD11B1 P28845 1/20 0.33
HTR7 P34969 1/20 0.32
HTT P42858 1/20 0.32
HTR3A P46098 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19100727 0.78 RPS6KA5 (0.46) RPS6KA5CDC7CDK2HSD11B1
SCHEMBL28619077 0.76 ALDH1A1 (0.51) RPS6KA5PTGDR2CYP17A1HTT
SCHEMBL28603774 0.75 PTGDR2 (0.48) RPS6KA5PTGDR2HTR3A
SCHEMBL28605417 0.74 RPS6KA5 (0.46) RPS6KA5PTGDR2CYP17A1CDC7CDK2
SCHEMBL28605717 0.72 PTGDR2 (0.57) RPS6KA5PTGDR2HTR7
SCHEMBL28961614 0.72 PTGDR2 (0.48) RPS6KA5PTGDR2CYP17A1CDC7CDK2
SCHEMBL5096787 0.71 HTR6 (0.34) HTR6CDC7CDK2
SCHEMBL30752267 0.70 CA1 (0.45) HTR7HTR3A
SCHEMBL19336961 0.69 L3MBTL1 (0.55) CDK2
SCHEMBL17993426 0.69 PTGDR2 (0.56) RPS6KA5PTGDR2CYP17A1LCKCDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109328059-B Selective inhibitors of clinically important mutants of EGFR tyrosine kinase CS制药技术有限公司 2021-08-17 CN disclosed
CN-109328059-A Selective inhibitors of clinically important mutants of EGFR tyrosine kinase CS制药技术有限公司 2019-02-12 CN disclosed